Cargando…

A short-term in vivo model for giant cell tumor of bone

BACKGROUND: Because of the lack of suitable in vivo models of giant cell tumor of bone (GCT), little is known about its underlying fundamental pro-tumoral events, such as tumor growth, invasion, angiogenesis and metastasis. There is no existing cell line that contains all the cell and tissue tumor c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balke, Maurice, Neumann, Anna, Szuhai, Károly, Agelopoulos, Konstantin, August, Christian, Gosheger, Georg, Hogendoorn, Pancras CW, Athanasou, Nick, Buerger, Horst, Hagedorn, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125284/ https://www.ncbi.nlm.nih.gov/pubmed/21668953 http://dx.doi.org/10.1186/1471-2407-11-241

Ejemplares similares

Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane
por: Balke, Maurice, et al.
Publicado: (2010)

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone
por: Balke, Maurice, et al.
Publicado: (2010)

Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma
por: Venneker, Sanne, et al.
Publicado: (2019)

Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families
por: Jennes, Ivy, et al.
Publicado: (2011)

Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis
por: Forsyth, Ramses G., et al.
Publicado: (2021)

Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples
por: de Jong, Danielle, et al.
Publicado: (2011)

Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH
por: Cliteur, Vincent PM, et al.
Publicado: (2012)

Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes
por: Sand, Laurens G. L., et al.
Publicado: (2015)

A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes
por: Romeo, Salvatore, et al.
Publicado: (2009)

Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy
por: Sand, Laurens G. L., et al.
Publicado: (2016)

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
por: Willems, Stefan M, et al.
Publicado: (2010)

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)

Treatment and outcome of giant cell tumors of the pelvis: 20 cases followed for 1 to 11 years
por: Balke, Maurice, et al.
Publicado: (2009)

Giant Cell Tumors of the Axial Skeleton
por: Balke, Maurice, et al.
Publicado: (2012)

Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature
por: Mremi, Alex, et al.
Publicado: (2021)

Genome-wide analysis of Ollier disease: Is it all in the genes?
por: Pansuriya, Twinkal C, et al.
Publicado: (2011)

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
por: van Oosterwijk, Jolieke G, et al.
Publicado: (2012)

Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic “Stromal” Cells from Giant Cell Tumors of Bone
por: Venneker, Sanne, et al.
Publicado: (2022)

Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis
por: da Costa, Cristiana E.T., et al.
Publicado: (2005)

Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial
por: Lipplaa, Astrid, et al.
Publicado: (2019)

Site-specific chromatin immunoprecipitation: a selective method to individually analyze neighboring transcription factor binding sites in vivo
por: Schuch, Ronaldo, et al.
Publicado: (2012)

Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features
por: Mertens, Fredrik, et al.
Publicado: (2011)

Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway
por: Nord, Karolin H., et al.
Publicado: (2013)

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011)

The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012)

Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma
por: Sand, Laurens G. L., et al.
Publicado: (2017)

Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast
por: Agelopoulos, Konstantin, et al.
Publicado: (2007)

Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours
por: Verdegaal, Suzan HM, et al.
Publicado: (2012)

Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches
por: van der Wal, Steffen, et al.
Publicado: (2018)

Multiple Osteochondromas: Clinicopathological and Genetic Spectrum and Suggestions for Clinical Management
por: Hameetman, Liesbeth, et al.
Publicado: (2004)

Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture
por: Buddingh, Emilie P, et al.
Publicado: (2015)

High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy
por: Leidinger, Benedikt, et al.
Publicado: (2006)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

Selective regain of egfr gene copies in CD44(+)/CD24(-/low )breast cancer cellular model MDA-MB-468
por: Agelopoulos, Konstantin, et al.
Publicado: (2010)

Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
por: Buddingh, Emilie P., et al.
Publicado: (2011)

Neoadjuvant denosumab for extensive giant cell tumor in os ischium —a case report
por: van der Heijden, Lizz, et al.
Publicado: (2015)

Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma
por: Bosma, Sarah E, et al.
Publicado: (2018)

Increased dynamin expression precedes proteinuria in glomerular disease
por: Khalil, Ramzi, et al.
Publicado: (2018)

Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath.
por: Athanasou, N. A., et al.
Publicado: (1991)

Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
por: Kuijjer, Marieke L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vgbhr3uvhv4ufpkqb380d02idv